Literature DB >> 410589

Inhibition of prostaglandin synthesis and leucocyte migration by flurbiprofen.

S S Adams, C A Burrows, N Skeldon, D B Yates.   

Abstract

The carrageenan air pouch technique in the rat was used to investigate the effects of flurbiprofen, a non-steroidal anti-inflammatory agent, on prostaglandin production and leucocyte migration. tthere is a suggestion that flurbiprofen was capable of inhibiting prostaglandin synthesis at doses lower than those which were effective in reducing leucocyte migration. Therefore, these two effects may reflect independent actions of the drug. The possible clinical relevance of these experiments has been noted since the effects of flurbiprofen on prostaglandin synthesis and leucocyte migration are produced in the rat at peak plasma concentrations which are less than those found in man after a single dose of 50 mg.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 410589     DOI: 10.1185/03007997709108969

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  6 in total

1.  The effects of flurbiprofen on the passive transfer of adjuvant-induced arthritis.

Authors:  G W Cannon; D S Harper
Journal:  Agents Actions       Date:  1992-01

2.  The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis.

Authors:  M A Young; L Aarons; S Toon
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

3.  Does the addition of ketotifen to non-steroidal anti-inflammatory drugs confer any additional benefit in rheumatoid arthritis?

Authors:  L G Teh; R Madhok; H A Capell
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

4.  Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.

Authors:  S M Weisman; M J Doyle; K R Wehmeyer; B A Hynd; T H Eichhold; R M Clear; C W Coggeshall; D L Kuhlenbeck
Journal:  Agents Actions       Date:  1994-05

Review 5.  Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-12       Impact factor: 9.546

6.  Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.

Authors:  L Aarons; R Salisbury; M Alam-Siddiqi; L Taylor; D M Grennan
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.